Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
Clinical guideline published by Evaluation of Genomic Applications in Practice and Prevention (EGAPP) on
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) aims to create a systematic, evidence-based framework for assessing genetic tests and genomic technologies. Established in 2005, it prioritizes tests, reviews evidence, and provides guidance for clinical use.